“여성 건강 진단 시장 예측 - 세계 전망(-2030년)”에서는 임상, 포인트 오브 케어(POC), 일반 의약품(OTC)의 각 분야에 있어서의 여성의 건강에 특화한 진단 검사의 세계의 상황에 대해, 종합적이고 데이터에 근거해 분석했습니다. 오랫동안 살아가면서 건강 관리 시스템은 질병 위험, 스크리닝 및 치료의 성별을 인식하고 이에 대처할 필요가 있습니다.
이 상세한 보고서는 2030년까지의 진단 검사와 진단 시스템 세계 시장 동향을 예측하고 여성의 건강과 관련된 폭넓은 진단 카테고리에 대해 지역 구분과 동향 분석을 실시합니다. 유행하는 질병의 감지, 스크리닝, 모니터링에 사용되는 기존 기술과 신기술을 모두 다루고 있습니다.
이 보고서에서 다루는 주요 진단 분야는 다음과 같습니다.
유방과 생식기의 건강 영상 : 유방 조영술, CADe/CADx, 산부인과 초음파, 유방 초음파 영상 진단
산전 검사 및 보균자 선별 검사 : 비침습적 산전 검사(NIPT), 보균자 선별 검사, 모체 태아 진단
감염병 및 성매개 감염병 : HPV 진단, TORCH 면역검정, 분자 요로 감염(UTI) 검사
불임 및 임신 검사 : 배란, 배란 호르몬, 임신 상태의 실험실 기반 및 POC 검사
암 및 만성 질환 모니터링 : 팝 테스트, 난소암 바이오마커, 여성 특이 자가면역 면역 분석
뼈 건강 및 예방 진단 : 조기 암 발견을위한 골밀도 측정 검사 및 콜포스코피 시스템
각 장에서는 규제 변화, 상환, 시장 진입, 제품 차별화 등의 과제를 다루면서 각 카테고리의 성장을 견인하는 과학적 기반과 기술 혁신을 탐구하고 있습니다.
압도적인 다국적 기업에서 민첩한 틈새 기업까지 다양한 진단 기업들을 각 카테고리에서 소개합니다.
진단검사가 의료상 의사결정의 70% 이상을 좌우하는 현재, 본 보고서는 여성 건강 진단을 성장시장으로서 뿐만 아니라 정밀의료의 중요한 구성요소로 자리매김하고 있습니다.
목차
리서치사에 대하여
제1장 주요 요약
제2장 소개
여성의 건강 : 개선의 여지
여성의 건강에 관한 관점
여성과 남성에서는 일부 질병의 발병이 다르다
통증
심장
뇌
감정
뼈의 구조
알코올
약 부작용
흡연
생식능력
성감염증과 HIV
자가면역질환
암
여성에게 많은 암
근골격계의 건강
선천이상
요로 감염(UTI)
여성의 건강 진단에 있어서의 주요한 동향과 과제
난소암의 진단과 바이오마커
HPV 검사
보다 광범위한 보균자 선별 검사과 NIPT
요로 감염의 멀티플렉스 검사와 분자 검사
영상 및 AI
임신 및 배란
자가면역 검사
제3장 유방 조영술
소개
유방 조영술 시장
컴퓨터 지원 검출/진단(CADe/CADx)
유방 화상 진단에 있어서의 인공지능 도입
규제 변경
경쟁 구도
Fujifilm Holdings Corp.
GE HealthCare
Hologic
Siemens Healthineers
제4장 초음파
소개
산부인과
유방 영상 검사
시장 동향
산부인과 초음파 동향
유방 영상 진단 시장
경쟁 구도
GE HealthCare
Hologic
Philips
Siemens Healthineers
제5장 산전 선별 검사 및 보균자 선별 검사
소개
NIPT
유전학의 진보는 새로운 과제를 가져온다
보균자 선별 검사
테스트 도입 동향
유전성 질환
M&A, 파트너십
NIPT와 보균자 선별 검사 시장
경쟁 구도
Agilent
Illumina
Qiagen
Revvity
Thermo Fisher Scientific
제6장 HPV 검사
소개
개요
HPV IVD 검사 시장
HPV 검사 및 세계 선별 프로그램
경쟁 구도
BD(Becton, Dickinson and Company)
Hologic
QIAGEN
Roche
제7장 임신과 배란
소개
테스트에 관한 관점
디지털 테스트
실험실 테스트
동향
시장
제품
TORCH 테스트
경쟁 구도
시장 진출기업
NowDiagnostics Inc.
Salignostics
Sekisui
Acon
Major Companies
Abbott
Beckman Coulter(Danaher)
bioMerieux
Church & Dwight
Roche
Siemens Healthineers
제8장 Pap Smears
소개
자궁 경부암 검사
동향
Pap Test Market
경쟁 구도
BD(Becton Dickinson)
Hologic
제9장 자가면역질환
소개
유전적 요인
여성 환자에 미치는 영향
최근 동향
여성자가 면역 질환의 실험실 기반 면역 측정 시장
경쟁 구도
Bio-Rad
Euroimmun(Revvity)
Thermo Fisher Scientific
제10장 골밀도 검사
소개
골다공증의 놀라운 증가
측정의 필요성을 추진
DEXA와 경쟁 기술의 동향
골밀도 측정 시장
경쟁 구도
DMS Imaging(European Medical Solutions)
GE HealthCare
Hologic
제11장 질 확대경 검사
소개
자궁 경부암의 선별 및 진단
동향
질 확대경 검사 시스템 시장
경쟁 구도
Apgar Danmark A/S
CooperSurgical
Olympus
제12장 요로 감염증
소개
이환과 사망의 주요 원인
임팩트
동향
기술 발전이 임상 가이드라인을 능가함
차세대 시퀀싱(NGS)
멀티플렉스 PCR, qPCR
UTI 분자 검사 시장
경쟁 구도
중소기업의 가능성
기업의 하이라이트
BioGX
Camtech
PathogenDx
Randox Laboratories
RayBiotech
Thermo Fisher Scientific
제13장 난소암
소개
난소암의 유형
CA-125
동향
다변량 지수 분석 및 유전체 검사
난소암 바이오마커 시장
경쟁 구도
기업의 하이라이트
Abbott
Fujirebio
Illumina
Roche
Thermo Fisher Scientific
SHW
영문 목차
영문목차
Kalorama Information's "Women's Health Diagnostic Markets: Global Outlook and Forecast to 2030" offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women's health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift-with women living longer than men-healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman's life span.
This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.
Key diagnostic sectors covered in the report include:
Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.
Each chapter explores the scientific foundations and technological innovations driving growth in its respective category while addressing challenges such as regulatory shifts, reimbursement, market access, and product differentiation. The report draws on interviews with industry experts, input from clinical labs, and extensive primary and secondary research to inform market forecasts and trend assessments.
A diverse group of diagnostic players-ranging from dominant multinationals to nimble niche firms-are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.
At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women's health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women's evolving health needs.
Table of Contents
About Kalorama Information
Chapter 1: Executive Summary
Overview
Scope and Methodology
Market Overview and Potential
Figure 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
Table 1-1: World Markets for Key Women's Health Diagnostics, by Product Segment, 2024-2030 ($ million) [Autoimmune immunoassay, Bone densitometry, CADe/CADx, Colposcopy systems, Female HPV IVD tests, Lab based fertility immunoassay, Lab based TORCH immunoassay, Mammography, Molec. prenatal, carrier, NIPT, Molecular UTI tests for females, Ovarian cancer immunoassays, Pap tests, POC pregnancy & fertility, Ultrasound breast imaging, Ultrasound OB/GYN]
Chapter 2: Introduction
Female Health: Room for Improvement
Perspective on Women's Health
Women and Men Develop Some Diseases Differently
Pain
The Heart
The Brain
Emotions
Bone Structure
Alcohol
Drug Side Effects
Smoking
Fertility
STIs and HIV
Autoimmune Disease
Cancer
Leading Female Cancers
Musculoskeletal Health
Congenital Abnormalities
Urinary Tract Infections (UTIs)
Key Trends and Issues in Women's Health Diagnostics
Ovarian Cancer Diagnostics and Biomarkers
HPV Testing
Broader Carrier Screening and NIPT
Multiplex and Molecular Testing for UTIs
Imaging and AI
Pregnancy and Ovulation
Autoimmune Laboratory Immunoassays
Chapter 3: Mammography
Introduction
Transition to Digital
Economics of Routine Screening
Digital Breast Tomosynthesis (DBT or 3D Mammography)
Mammography Market
Table 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 3-1: World Mammography Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 3-2: World Mammography Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 3-3: World Mammography Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Computer-Aided Detection/Diagnosis (CADe/CADx)
Table 3-2: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 3-4: World CADe/CADx Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 3-5: World CADe/CADx Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 3-6: World CADe/CADx Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Artificial Intelligence Adoption in Breast Imaging
Key Trends in AI-Driven CAD
Trends
Regulatory Changes
Competitive Landscape
Fujifilm Holdings Corp.
GE HealthCare
Hologic
Siemens Healthineers
Chapter 4: Ultrasound
Introduction
Table 4-1: Key Applications for Medical Ultrasound
Obstetrics and Gynecology
Breast Imaging
Market Trends
Obstetric and Gynecological Ultrasound Trends
Table 4-2: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 4-1: World Ultrasound OB/GYN Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 4-2: World Ultrasound OB/GYN Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 4-3: World Ultrasound OB/GYN Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Breast Imaging Market
Table 4-3: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 4-4: World Ultrasound Breast Imaging Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 4-5: World Ultrasound Breast Imaging Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 4-6: World Ultrasound Breast Imaging Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
GE HealthCare
Hologic
Philips
Siemens Healthineers
Chapter 5: Prenatal and Carrier Screening
Introduction
NIPT
Advances in Genetics Bring New Challenges
Carrier Screening
Test Adoption Trends
Inherited Diseases
Inflammatory Bowel Disease (IBD) and Crohn's Disease
Autism Spectrum Disorder (ASD)
Alzheimer's Disease (AD)
Cardiovascular Disease (CVD)
Psychiatric Disorders
M&A, Partnerships
NIPT and Carrier Screening Markets
Table 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 5-1: World Prenatal and Carrier Test, NIPT Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 5-2: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 5-3: World Prenatal and Carrier Test, NIPT Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Agilent
Illumina
Qiagen
Revvity
Thermo Fisher Scientific
Chapter 6: HPV Testing
Introduction
Overview
HPV Infection
Infection in Females
High-Risk Types and Cervical Cancer
HPV Testing
HPV IVD Test Market
Table 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 6-1: World Female HPV IVD Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 6-2: World Female HPV IVD Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 6-3: World Female HPV IVD Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
HPV Testing and Global Screening Programs
Competitive Landscape
BD (Becton, Dickinson and Company)
Hologic
QIAGEN
Roche
Chapter 7: Pregnancy and Ovulation
Introduction
Perspective on Testing
Digital Testing
Lab Testing
Trends
Market
POC Pregnancy and Fertility Test Market
Table 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-1: World POC Pregnancy Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-2: World POC Pregnancy Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 7-3: World POC Pregnancy Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Table 7-2: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-4: World Lab-Based Fertility Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-5: World Lab-Based Fertility Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 7-6: World Lab-Based Fertility Immunoassay Market, Share by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Products
TORCH Testing
Table 7-3: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-7: World Lab-Based TORCH Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 7-8: World Lab-Based TORCH Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 7-9: World Lab-Based TORCH Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Market Participants
NowDiagnostics Inc.
Salignostics
Sekisui
Acon
Major Companies
Abbott
Beckman Coulter (Danaher)
bioMerieux
Church & Dwight
Roche
Siemens Healthineers
Chapter 8: Pap Smears
Introduction
Testing for Cervical Cancer
Trends
Pap Test Market
Table 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 8-1: World IVD Traditional Pap Test Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 8-2: World IVD Traditional Pap Test Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 8-3: World IVD Traditional Pap Test Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
BD (Becton Dickinson)
Hologic
Chapter 9: Autoimmune Disease
Introduction
Genetic Factors
Impact on Female Patients
Recent Developments
Female Autoimmune Lab-Based Immunoassay Market
Table 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 9-1: World Female Lab-Based Autoimmune Immunoassay Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 9-2: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World] ($ million)
Figure 9-3: World Female Lab-Based Autoimmune Immunoassay Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
Bio-Rad
Euroimmun (Revvity)
Thermo Fisher Scientific
Chapter 10: Bone Density Testing
Introduction
Alarming Rise in Osteoporosis
Propelling the Need for Measurement
Trends in DEXA and Competing Technologies
DEXA: The Gold Standard
Emerging Trends and Accessibility
Bone Densitometry Market
Table 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 10-1: World Bone Densitometry for Female Testing Market, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 10-2: World Bone Densitometry for Female Testing Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 10-3: World Bone Densitometry for Female Testing Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
Competitive Landscape
DMS Imaging (European Medical Solutions)
GE HealthCare
Hologic
Chapter 11: Colposcopy
Introduction
Cervical Cancer Screening and Diagnosis
Trends
Colposcopy Systems Market
Table 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 11-1: World Colposcopy Systems Market Share, by Region, 2024-2030 ($ million) [APAC, Europe, North America, Rest of World]
Figure 11-2: World Colposcopy Systems Market Share, by Region, 2024 (%) [APAC, Europe, North America, Rest of World]
Figure 11-3: World Colposcopy Systems Market Share, by Region, 2030 (%) [APAC, Europe, North America, Rest of World]
